Intensive Lipid Lowering With Atorvastatin in Patients With Coronary Heart Disease and Chronic Kidney Disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Intensive Lipid Lowering With Atorvastatin in Patients With Coronary Heart Disease and Chronic Kidney Disease

Published:2008-04 Issue:15 Volume:51 Page:1448-1454
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Shepherd James,Kastelein John J.P.,Bittner Vera,Deedwania Prakash,Breazna Andrei,Dobson Stephen,Wilson Daniel J.,Zuckerman Andrea,Wenger Nanette K.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference19 articles.

1. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification;Levey;Ann Intern Med,2003

2. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention;Sarnak;Circulation,2003

3. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization;Go;N Engl J Med,2004

4. How does minor renal dysfunction influence cardiovascular risk and the management of cardiovascular disease?;Pinkau;J Am Soc Nephrol,2004

5. Cardiovascular disease risk factors in chronic kidney disease: overall burden and rates of treatment and control;Parikh;Arch Intern Med,2006

Cited by 273 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enfermedad renal crónica y mortalidad cardiovascular. Un factor de riesgo ignorado;Medicina Clínica Práctica;2024-07

2. Outcomes of carotid revascularization stratified by procedure in patients with an estimated glomerular filtration rate of <30 and dialysis patients;Journal of Vascular Surgery;2024-06

3. Australian and New Zealand Living Guideline cholesterol‐lowering therapy for people with chronic kidney disease (CARI Guidelines): Reducing the evidence‐practice gap;Nephrology;2024-04-29

4. Lipoprotein dysfunction in patients with chronic kidney disease (CKD). Pathogenesis and treatment of CKD dyslipidemia (literature review);Nephrology (Saint-Petersburg);2024-03-03

5. Increased Cardiovascular Risk in Young Patients with CKD and the Role of Lipid-Lowering Therapy;Current Atherosclerosis Reports;2024-01-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3